Zentalis Pharmaceuticals, Inc. (ZNTL) Net Income by Year
Zentalis Pharmaceuticals, Inc. reported a net loss of $137.1M in fiscal year 2025. This represents an increase of 17.4% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Zentalis Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ZNTL Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ZNTL Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Zentalis Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Zentalis Pharmaceuticals, Inc.'s net income in fiscal year 2025?
Zentalis Pharmaceuticals, Inc. reported a net loss of $137.1M in fiscal year 2025.
How fast is Zentalis Pharmaceuticals, Inc.'s net income growing?
Zentalis Pharmaceuticals, Inc. (ZNTL) net income rose by 17.4% year over year, from -$165.9M to -$137.1M in fiscal year 2025.
How has Zentalis Pharmaceuticals, Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, Zentalis Pharmaceuticals, Inc. (ZNTL) net income went from -$45.7M in fiscal year 2019 to -$137.1M in fiscal year 2025.
What was Zentalis Pharmaceuticals, Inc.'s net income in the most recent quarter?
Zentalis Pharmaceuticals, Inc. (ZNTL) reported -$42.3M in net income in Q2 2026. This represents a decrease of 57.3% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Zentalis Pharmaceuticals, Inc. (ZNTL) reported on that line in every period on record.